KEVIN RAKIN
CIK 1184421 · last filed 2026-05-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.83M
Companies
6
Total Filings
48
Lifetime Open-Market Net
$74.62M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QSI | Director | 1,220,512 | $0.95 | $1.16M | -$191.2K | 8 | 2026-05-20 |
| ELUT | Director | 518,539 | $0.96 | $497.8K | $296.8K | 5 | 2026-02-02 |
| ORMP | Director | 46,661 | $3.87 | $180.6K | -$536.9K | 17 | 2022-03-22 |
| ELUTIA INC. (AZYO) Delisted | Director | 4,062,451 | $1.49 | $6.05M | $75.00M | 1 | 2020-10-13 |
| Omrix Biopharmaceuticals, Inc. (OMRI) Delisted | Director | 6,000 | — | — | $27.3K | 4 | 2008-09-05 |
| VION PHARMACEUTICALS INC (VION) Delisted | Director | 61,000 | — | — | $23.9K | 3 | 2007-06-28 |
Recent Filings · Page 5 of 5
48 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-12-12 | — | Grant (A) | +1,130 | $0 | |
| 2008-09-05 | Omrix Biopharmaceuticals, Inc. (OMRI) Delisted | Grant (A) | +2,000 | $0 | EDGAR |
| 2008-03-28 | Omrix Biopharmaceuticals, Inc. (OMRI) Delisted | Buy (P) | +2,000 | $27.3K | EDGAR |
| 2007-06-28 | VION PHARMACEUTICALS INC (VION) Delisted | Grant (A) | +11,300 | $0 | EDGAR |
| 2007-06-01 | Omrix Biopharmaceuticals, Inc. (OMRI) Delisted | Grant (A) | +2,000 | $0 | EDGAR |
| 2007-03-15 | VION PHARMACEUTICALS INC (VION) Delisted | Buy (P) | +15,000 | $23.9K | EDGAR |
| 2007-01-18 | Omrix Biopharmaceuticals, Inc. (OMRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-01-17 | VION PHARMACEUTICALS INC (VION) Delisted | Grant (A) | +34,700 | $0 | EDGAR |
Showing 41–48 of 48
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.